Canntab Therapeutics Ltd (PILL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 05-2019 | 02-2019 | 11-2018 | 08-2018 | 05-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 414 | 2,428 | 3,061 | 3,496 | 4,218 |
| Marketable Securities | 1,175 | N/A | N/A | N/A | N/A |
| Receivables | 240 | 288 | 256 | 229 | 170 |
| TOTAL | $1,904 | $2,733 | $3,348 | $3,785 | $4,464 |
| Non-Current Assets | |||||
| PPE Net | 343 | 275 | 274 | 242 | 160 |
| Intangibles | 180 | 152 | 155 | 151 | 126 |
| Other Non-Current Assets | 167 | 0 | 0 | 0 | 0 |
| TOTAL | $689 | $427 | $429 | $393 | $286 |
| Total Assets | $2,593 | $3,159 | $3,777 | $4,178 | $4,749 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 51 | 10 | 2 | 52 | 215 |
| Accrued Expenses | 135 | 140 | 117 | 79 | 58 |
| TOTAL | $232 | $241 | $208 | $172 | $314 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 40 | 90 | 90 | 40 | 40 |
| TOTAL | $93 | $228 | $251 | $123 | $133 |
| Total Liabilities | $326 | $469 | $459 | $295 | $447 |
| Shareholders' Equity | |||||
| Common Shares | 6,554 | 6,539 | 6,539 | 6,517 | 6,517 |
| Retained earnings | -5,983 | -5,435 | -4,759 | -3,972 | -3,525 |
| TOTAL | $2,268 | $2,690 | $3,318 | $3,883 | $4,302 |
| Total Liabilities And Equity | $2,593 | $3,159 | $3,777 | $4,178 | $4,749 |